GC Cell, under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005

Lipocine Inc. a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics

Centivax, a biotechnology company that develops broad-spectrum vaccines to combat rapidly evolving pathogens, has announced a strategic collaboration

Glenmark Therapeutics Inc., USA is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)

GBM Health Holding, a global leader in integrated healthcare innovation, is proud to announce that its subsidiaries Gene Biotechnology Enterprises Ltd

Moleculin Biotech, Inc. a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses

HanAll Biopharma Co., Ltd. a global biopharmaceutical company committed to discovering and developing innovative medicines for patients

CStone Pharmaceuticals, a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission

Bioheng Therapeutics US LLC, a clinical-stage biotech company dedicated to developing innovative universal CAR-T cell therapies